Literature DB >> 22673994

Peroxiredoxin sets the brain on fire after stroke.

Lidia Garcia-Bonilla, Costantino Iadecola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22673994      PMCID： PMC3955950          DOI： 10.1038/nm.2797

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  16 in total

1.  Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity.

Authors:  Takayuki Kawano; Josef Anrather; Ping Zhou; Laibaik Park; Gang Wang; Kelly A Frys; Alexander Kunz; Sunghee Cho; Marcello Orio; Costantino Iadecola
Journal:  Nat Med       Date:  2006-01-06       Impact factor: 53.440

2.  Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.

Authors:  Alexander Kunz; Takato Abe; Karin Hochrainer; Munehisa Shimamura; Josef Anrather; Gianfranco Racchumi; Ping Zhou; Costantino Iadecola
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

3.  Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain.

Authors:  Takashi Shichita; Eiichi Hasegawa; Akihiro Kimura; Rimpei Morita; Ryota Sakaguchi; Ichiro Takada; Takashi Sekiya; Hiroaki Ooboshi; Takanari Kitazono; Toru Yanagawa; Tetsuro Ishii; Hideo Takahashi; Shuji Mori; Masahiro Nishibori; Kazumichi Kuroda; Shizuo Akira; Kensuke Miyake; Akihiko Yoshimura
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

4.  Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.

Authors:  Ahmet Arac; Sara E Brownell; Jonathan B Rothbard; Charlene Chen; Rose M Ko; Marta P Pereira; Gregory W Albers; Lawrence Steinman; Gary K Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-26       Impact factor: 11.205

5.  Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.

Authors:  Gregory W Albers; Larry B Goldstein; David C Hess; Lawrence R Wechsler; Karen L Furie; Philip B Gorelick; Patty Hurn; David S Liebeskind; Raul G Nogueira; Jeffrey L Saver
Journal:  Stroke       Date:  2011-08-18       Impact factor: 7.914

Review 6.  Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.

Authors:  Kazuhide Hayakawa; Jianhua Qiu; Eng H Lo
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury.

Authors:  Takashi Shichita; Yuki Sugiyama; Hiroaki Ooboshi; Hiroshi Sugimori; Ryusuke Nakagawa; Ichiro Takada; Toru Iwaki; Yasunori Okada; Mitsuo Iida; Daniel J Cua; Yoichiro Iwakura; Akihiko Yoshimura
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

8.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits.

Authors:  Sung-Chun Tang; Thiruma V Arumugam; Xiangru Xu; Aiwu Cheng; Mohamed R Mughal; Dong Gyu Jo; Justin D Lathia; Dominic A Siler; Srinivasulu Chigurupati; Xin Ouyang; Tim Magnus; Simonetta Camandola; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-10       Impact factor: 11.205

9.  Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage.

Authors:  C Iadecola; F Zhang; X Xu
Journal:  Am J Physiol       Date:  1995-01

Review 10.  The immunology of stroke: from mechanisms to translation.

Authors:  Costantino Iadecola; Josef Anrather
Journal:  Nat Med       Date:  2011-07-07       Impact factor: 53.440
View more
  17 in total

Review 1.  Inflammation and Stroke: An Overview.

Authors:  Josef Anrather; Costantino Iadecola
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

2.  Prx2 (Peroxiredoxin 2) as a Cause of Hydrocephalus After Intraventricular Hemorrhage.

Authors:  Xiaoxiao Tan; Jingyin Chen; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Stroke       Date:  2020-04-13       Impact factor: 7.914

Review 3.  Autonomic regulation of the immune system in cardiovascular diseases.

Authors:  François M Abboud; Madhu V Singh
Journal:  Adv Physiol Educ       Date:  2017-12-01       Impact factor: 2.288

Review 4.  The Immune Response to Acute Focal Cerebral Ischemia and Associated Post-stroke Immunodepression: A Focused Review.

Authors:  Bolanle M Famakin
Journal:  Aging Dis       Date:  2014-10-01       Impact factor: 6.745

5.  Intracerebral Hemorrhage-Induced Brain Injury in Rats: the Role of Extracellular Peroxiredoxin 2.

Authors:  Liheng Bian; Jingwei Zhang; Ming Wang; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2019-07-04       Impact factor: 6.829

Review 6.  Pathogenic mechanisms following ischemic stroke.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Maryam Farzaneh; Yaghoob Farbood; Hadi Fathi Moghaddam
Journal:  Neurol Sci       Date:  2017-04-17       Impact factor: 3.307

7.  Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.

Authors:  Clémentine Aguirre; Tim ten Brink; Jean-François Guichou; Olivier Cala; Isabelle Krimm
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

8.  The effect of subarachnoid erythrocyte lysate on brain injury: a preliminary study.

Authors:  Zi-Huan Zhang; Yan-Ling Han; Chun-Xi Wang; Chen-Hui Zhou; Ling-Yun Wu; Hua-Sheng Zhang; Qiang Chen; Jie-Mei Fan; Meng-Liang Zhou; Chun-Hua Hang
Journal:  Biosci Rep       Date:  2016-07-15       Impact factor: 3.840

9.  Differences in Proinflammatory Property of Six Subtypes of Peroxiredoxins and Anti-Inflammatory Effect of Ligustilide in Macrophages.

Authors:  Li-Xue Zhao; Jun-Rong Du; Hong-Jing Zhou; Dong-Ling Liu; Man-Xia Gu; Fang-Yi Long
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

10.  Diagnostic performance of peroxiredoxin 1 to determine time-of-onset of acute cerebral infarction.

Authors:  Sébastien Richard; Vanessa Lapierre; Nicolas Girerd; Mathieu Bonnerot; Pierre R Burkhard; Linnéa Lagerstedt; Serge Bracard; Marc Debouverie; Natacha Turck; Jean-Charles Sanchez
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.